Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-132

‘I wouldn’t be surprised if Shyam Masrani has discovered a target and been working on it for some years but hit a road block that starpharma can likely solve.’ ~ @bid

Possibly, possibly not. AstraZeneca had been working on a problematic drug for many many years and thought Starpharma’s DEP might have been the magic solution.

Unfortunately no. Twelve years and 3 terminated trials later the problem wasn’t solved.

At least with the AstraZeneca partnership Starpharma received an upfront licence fee and milestone payments!!!